The overall goal of Project P-2 is to test the hypothesis that extracellular proteases are key determinants of the remodeling of the airway epithelium glands, extracellular matrix, and vasculature that contribute to the perpetuation of and morbidity from chronic airway inflammation. Dr. Caughey and his colleagues will address this issue by performing in vivo studies of selected proteases and their targets in genetically altered mice, including those infected with Mycoplasma pulmonis as a model of chronic airway disease, and in vitro studies of molecular behavior and targets of these proteases.
Aim 1 is to determine the roles of proteinase-activated receptors (PARs) in airway remodeling, with a focus on thrombin and mast cell tryptase as activating ligands of PAR-1 and PAR-2, which may mediate growth-promoting effects of these proteases on airway glands and smooth muscle. The role of these receptors in airway remodeling will be examined by localization sites of PAR expression in normal and inflamed airways and exploring airway remodeling in PAR-null mice.
Aim 2 is to explore roles of proteases in extracellular matrix remodeling in PAR-null mice.
Aim 2 is to explore roles of proteases in extracellular matrix remodeling in chronic airway inflammation, seeking particularly to understand the importance of the matrix metalloproteinase gelatinase B and a thiol protease, dipeptidyl peptidase I. The laboratory's previous experiments suggest that both proteases are secreted and activated by mast cells, which may be an important source of these enzymes in airway remodeling. In these experiments we will localize proteases expression in airway microenvironments and examine mycoplasma-induced remodeling in gelatinase and dipeptidyl peptidase-null mice.
Aim 3 is to explore the roles of mast cell proteases in vascular remodeling in airway inflammation, focusing on protease-mediated formation and degradation of angiogenic and angiostatic proteins. The approach here is to establish molecular mechanisms of angiotropic factor generation and to deficient mice. Understanding mechanisms underlying these changes may identify previously unexplored strategies to prevent or reverse anatomical changes accompanying chronic airway inflammation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL024136-23
Application #
6491089
Study Section
Project Start
2001-07-01
Project End
2002-06-30
Budget Start
Budget End
Support Year
23
Fiscal Year
2001
Total Cost
$142,703
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Ma, Qiaoli; Dieterich, Lothar C; Ikenberg, Kristian et al. (2018) Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread. Sci Adv 4:eaat4758
Kim, Minah; Nitschké, Maximilian; Sennino, Barbara et al. (2018) Amplification of Oncolytic Vaccinia Virus Widespread Tumor Cell Killing by Sunitinib through Multiple Mechanisms. Cancer Res 78:922-937
Nitschké, Maximilian; Bell, Alexander; Karaman, Sinem et al. (2017) Retrograde Lymph Flow Leads to Chylothorax in Transgenic Mice with Lymphatic Malformations. Am J Pathol 187:1984-1997
Shepherd, Joanna; Fisher, Matthew; Welford, Abigail et al. (2017) The protective role of sphingosine-1-phosphate against the action of the vascular disrupting agent combretastatin A-4 3-O-phosphate. Oncotarget 8:95648-95661
Baluk, Peter; Yao, Li-Chin; Flores, Julio C et al. (2017) Rapamycin reversal of VEGF-C-driven lymphatic anomalies in the respiratory tract. JCI Insight 2:
Greenland, John R; Wong, Charissa M; Ahuja, Rahul et al. (2016) Donor-Reactive Regulatory T Cell Frequency Increases During Acute Cellular Rejection of Lung Allografts. Transplantation 100:2090-8
Huang, Jennifer L; Woolf, Adrian S; Kolatsi-Joannou, Maria et al. (2016) Vascular Endothelial Growth Factor C for Polycystic Kidney Diseases. J Am Soc Nephrol 27:69-77
Caughey, George H (2016) Mast cell proteases as pharmacological targets. Eur J Pharmacol 778:44-55
Korhonen, Emilia A; Lampinen, Anita; Giri, Hemant et al. (2016) Tie1 controls angiopoietin function in vascular remodeling and inflammation. J Clin Invest 126:3495-510
Kim, Minah; Allen, Breanna; Korhonen, Emilia A et al. (2016) Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation. J Clin Invest 126:3511-25

Showing the most recent 10 out of 593 publications